-
公开(公告)号:US20210283122A1
公开(公告)日:2021-09-16
申请号:US16328620
申请日:2017-08-25
申请人: TAKEDA GMBH
IPC分类号: A61K31/473 , A61P3/06 , A61P1/16 , A61P3/10
摘要: The present invention is directed to methods for the treatment of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steato-hepatitis (NASH) with a phosphodiesterase 4 (PDE4) inhibitor.